Phylogeography of Bufo marinus from its natural and introduced ranges.

Yazar: Slade, R W, Moritz, C
Baskı/Yayın Bilgisi 1998

Overdominant Vs. Frequency-Dependent Selection at Mhc Loci

Yazar: SLADE, R. W., MCCALLUM, H. I.
Baskı/Yayın Bilgisi 1992

A simple method for plasma exchange.

Yazar: Slade, R, Revill, J, Hutchinson, R M, Wood, J K
Baskı/Yayın Bilgisi 1978

Molecular population genetics of the southern elephant seal Mirounga leonina.

Yazar: Slade, R W, Moritz, C, Hoelzel, A R, Burton, H R
Baskı/Yayın Bilgisi 1998

An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre

Yazar: Sengupta, P S, Jayson, G C, Slade, R J, Eardley, A, Radford, J A
Baskı/Yayın Bilgisi 1999

Evolutionary dynamics of genetic variation in Epstein-Barr virus isolates of diverse geographical origins: evidence for immune pressure-independent genetic drift.

Yazar: Khanna, R, Slade, R W, Poulsen, L, Moss, D J, Burrows, S R, Nicholls, J, Burrows, J M
Baskı/Yayın Bilgisi 1997

Balloon Cell Urethral Melanoma: Differential Diagnosis and Management

Yazar: McComiskey, M., Iavazzo, C., Datta, M., Slade, R., Winter-Roach, B., Lambe, G., Sangar, V. K., Smith, M.
Yayımlandı Case Rep Obstet Gynecol (2015)

Requirement for expert histopathological assessment of ovarian cancer and borderline tumours

Yazar: Sengupta, P S, Shanks, J H, Buckley, C H, Ryder, W D J, Davies, J, Reynolds, K, Slade, R J, Kitchener, H C, Jayson, G C
Baskı/Yayın Bilgisi 2000

Carcinosarcoma of the ovary

Yazar: Harris, M A, Delap, L M, Sengupta, P S, Wilkinson, P M, Welch, R S, Swindell, R, Shanks, J H, Wilson, G, Slade, R J, Reynolds, K, Jayson, G C
Baskı/Yayın Bilgisi 2003

Antioxidant supplementation and nasal inflammatory responses among young asthmatics exposed to high levels of ozone

Yazar: SIENRA-MONGE, J J, RAMIREZ-AGUILAR, M, MORENO-MACIAS, H, REYES-RUIZ, N I, DEL RÍO-NAVARRO, B E, RUIZ-NAVARRO, M X, HATCH, G, CRISSMAN, K, SLADE, R, DEVLIN, R B, ROMIEU, I
Baskı/Yayın Bilgisi 2004

A phase I dose-escalation study of enzalutamide in combination with the AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

Yazar: Kolinsky, M.P., Rescigno, P., Bianchini, D., Zafeiriou, Z., Mehra, N., Mateo, J., Michalarea, V., Riisnaes, R., Crespo, M., Figueiredo, I., Miranda, S., Nava Rodrigues, D., Flohr, P., Tunariu, N., Banerji, U., Ruddle, R., Sharp, A., Welti, J., Lambros, M., Carreira, S., Raynaud, F.I., Swales, K.E., Plymate, S., Luo, J., Tovey, H., Porta, N., Slade, R., Leonard, L., Hall, E., de Bono, J.S.
Yayımlandı Ann Oncol (2020)